Science · Modern Medicine
how can digital twins improve individualized treatment planning in oncology?
Digital twins in oncology create a patient-specific computational model that integrates clinical imaging, pathology, genomics, and treatment history to simulate tumor behavior and therapy response. The concept of a digital
how will 3d bioprinting impact organ transplantation and recovery?
3D bioprinting promises to reshape organ transplantation by building living tissues layer by layer using cells and supportive biomaterials. Its relevance is driven by persistent organ shortage and the risks
what strategies reduce antimicrobial resistance in hospital-acquired infections?
Hospital-acquired infections drive selective pressure that accelerates antimicrobial resistance, undermining treatment options and increasing morbidity. The World Health Organization recommends multifaceted interventions to reduce this threat; evidence emphasizes that combining
what are current challenges in delivering gene therapies to the brain?
Delivering gene therapies to the brain faces scientific, clinical, and social obstacles that limit effectiveness and widen inequities. Researchers and regulators emphasize multiple interlocking challenges that must be addressed to
how will senolytic therapies impact age-related disease management?
Senescent cells accumulate with age and secrete a pro-inflammatory mix of factors known as the senescence-associated secretory phenotype that contributes to tissue dysfunction and chronic diseases. Senolytic therapies are drugs
how can organoid models improve personalized drug testing for cancer?
Organoid models offer a bridge between laboratory science and clinical decision-making by growing three-dimensional, patient-derived tissues that preserve key features of an individual’s tumor. Patient-derived organoids retain the genetic alterations,
how do mrna vaccines differ from traditional vaccines?
mRNA vaccines deliver a short strand of messenger RNA that encodes a specific pathogen protein rather than the pathogen itself. Research by Katalin Karikó, University of Pennsylvania, and Drew Weissman,
how are car-t therapies adapted for solid tumors?
Solid tumors pose distinct barriers to chimeric antigen receptor T cell adaptation: physical stroma that impedes infiltration, heterogeneous antigen expression that enables escape, and an immunosuppressive tumor microenvironment that drives
how will microbiome therapies influence metabolic disease treatment?
Gut microbes are increasingly seen as active agents in energy balance and glucose regulation rather than passive residents. Jeffrey I. Gordon at Washington University School of Medicine demonstrated that gut
how can personalized genomics guide cancer treatment decisions?
Genomic sequencing of a patient’s tumor and germline DNA can directly shape treatment choices by revealing actionable mutations, predicting response to therapies, and identifying inherited cancer risks. Clinical use of